Onesource Specialty Pharma Stock

Onesource Specialty Pharma Equity

The The Equity of Onesource Specialty Pharma (ONESOURCE.NS) as of Sep 4, 2026 is 58.81 B INR. In the previous year, The Equity was 3.96 B INR — a change of 1,386.07% (higher).

Equity

58.81 BINR

YoY

1,386.07%

Last updated:

In 2026, Onesource Specialty Pharma's equity was 58.81 B INR, a 1,386.07% increase from the 3.96 B INR equity in the previous year.

The Onesource Specialty Pharma Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2023
7.85 B INR
Jan 1, 2024
3.96 B INR
Jan 1, 2025
58.81 B INR
The Onesource Specialty Pharma Equity history
YEAREquityYoY
58.81 BINR+1,386.07%
3.96 BINR-49.62%
7.85 BINR—
Access this data via the Eulerpool API
Get Free API Key

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Onesource Specialty Pharma's Equity

Onesource Specialty Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Onesource Specialty Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Onesource Specialty Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Onesource Specialty Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Onesource Specialty Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Onesource Specialty Pharma stock

The Equity of Onesource Specialty Pharma is 58.81 B INR in 2026.

The Equity of Onesource Specialty Pharma changed from 3.96 B INR to 58.81 B INR, representing a 1,386.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Onesource Specialty Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Onesource Specialty Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Onesource Specialty Pharma